Galmed Pharmaceuticals - ADR Financials

$3.88

$-0.04 (-1.02%)

As on 04-Sep-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-6.32	-5.88	-6.14	-18.50	-32.89
Cash Flow from Investing Activities	--	-3.38	-1.11	0.80	17.56	11.46
Cash from Financing Activities	--	9.03	8.79	6.19	0.07	17.37
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-12.22	-1.57	-4.51	-16.44	-85.08	-1.29
Cash EPS ($)	-14.00	-1.57	-4.47	-16.36	-84.91	-1.29
Adjusted Book Value ($)	16.91	2.40	9.81	33.01	63.92	1.22
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.96	-3.53	-14.60	-88.10	-1.31
Free Cash Flow per Share ($)	--	-0.96	-3.53	-14.60	-88.12	-1.31

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-64.21	-49.70	-50.16	-80.54	-86.47
ROE (%)	-99.94	-64.21	-49.77	-50.63	-81.36	-86.98
ROA (%)	-61.34	-55.53	-42.80	-41.65	-67.21	-72.97
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	34.71	--	-8.71	60.90	45.56	-7.33
Net Profit Growth (%)	-63.39	-37.14	-8.75	61.31	44.97	-12.85
EPS Growth (%)	6.71	0.65	0.73	0.81	-64.74	0.99
Book Value Growth (%)	-67.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.48	-0.71	-0.03	-0.01	-1.41
Price / Book Value	0.29	0.31	0.33	0.01	0.01	1.50
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.32	1.28	1.35	1.81	0.76	-0.34
Close Price ($)	4.45	6.00	25.52	43.68	720.00	2,620.80
High Price ($)	18.72	28.88	190.40	1,360.80	3,139.06	9,000.00
Low Price ($)	3.29	5.85	20.48	24.96	417.60	2,476.94
Market Cap ($ Cr)	4.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	0.00	0.02	0.01
Short term debt to equity ratio	0.01	--	--	0.00	0.01	--
Current Ratio	4.16	6.55	7.42	4.81	4.76	6.13
Quick Ratio	4.16	--	--	--	4.72	6.29
Interest Coverage	-138.72	--	-500.13	-627.36	-82.10	-754.05

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	1,343.18	-4,268.21	-20,606.19
Payable days	--	--	7,012.36	26,150.72	38,773.90	51,817.67
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.